Merz - PharmaKB

Merz

Merz Pharma GmbH & Co. KGaA is a privately-held pharmaceutical company based in Frankfurt, Germany with affiliates across Europe, as well as the US, Canada, Mexico, Brazil and Asia Pacific and regional headquarters in Singapore and North Carolina, USA.

Download report

Favorite

Financial

Marketed Drugs

Clinical Trials

Financial

Stock price

No data

Company Revenue

No data

Revenue by Drug

Marketed Drugs

Therapeutic Areas:

All

Classification:

All

Include Generics:

Trade Name	Drug Name	Approved	Patent Expires	Indication
Axura	Memantine	2002-05-17	2025-2029	Alzheimer disease
Cuvposa	Glycopyrrolate	2010-07-28	2024-2038	Respiratory tract diseases , Peptic ulcer , Drug-induced abnormalities , Asthma , Bronchial spasm , Inflammatory bowel diseases , Allergic rhinitis perennial , Chronic bronchitis , Pulmonary emphysema , Urinary retention , Myasthenia gravis , Urinary bladder diseases
Erymax	Erythromycin	1985-07-11		Acne vulgaris , Bacterial infections , Gonorrhea , Campylobacter infections , Whooping cough , Chlamydia infections , Streptococcal infections , Legionnaires' disease , Urethritis , Bacterial eye infections , Syphilis , Staphylococcal infections , Mycoplasma infections , Protozoan infections , Gastroenteritis , Chancroid , Erythrasma , Rosacea
Memantine merz	Memantine	2012-11-22	2025-2029	Alzheimer disease
Xeomin	Incobotulinumtoxina	2010-07-30		Genetic skin diseases, Dystonia, Fissure in ano, Strabismus, Blepharospasm, Muscle rigidity
Inbrija	Levodopa	2018-12-21	2023-2039	Parkinson disease
Ampyra	Dalfampridine	2010-01-22		Multiple sclerosis, Neurologic gait disorders